Featured Press Releases

Stealth BioTherapeutics announces an FDA advisory committee meeting to review Elamipretide for Barth syndrome treatment

Stealth BioTherapeutics announces an FDA advisory committee meeting to review Elamipretide for Barth syndrome treatment

Novotech receives new investment from GIC, Temasek, and existing investor TPG to accelerate global growth

Novotech receives new investment from GIC, Temasek, and existing investor TPG to accelerate global growth

  • 12 Apr 2025

Novotech, a globally recognized full-service biotech specialist clinical research organization...

Transposon to share Phase 2 results of TPN-101 for C9orf72-related ALS/FTD at ALS ONE Research Symposium.

Transposon to share Phase 2 results of TPN-101 for C9orf72-related ALS/FTD at ALS ONE Research Symposium.

BerGenBio selects 2nd dose in Phase 2a STK11m Non-Small Cell Lung Cancer trial.

BerGenBio selects 2nd dose in Phase 2a STK11m Non-Small Cell Lung Cancer trial.

To Redefine Specialty Care, Craft Telemedicine Launches with a Human-Centered Platform

To Redefine Specialty Care, Craft Telemedicine Launches with a Human-Centered Platform

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

  • Vertanical
  • 09 Jun 2026
BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

  • Alpha Cognition Inc.
  • 09 Jun 2026
TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

  • TrueMed Ltd.
  • 08 Jun 2026
Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

  • TelyRx Holdings Inc.
  • 08 Jun 2026
Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

  • Beauty Crush Skincare
  • 04 Jun 2026
Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

  • Brain Navi Biotechnology
  • 04 Jun 2026
The Digital Pharma Advances Conference 2026

Most Popular
June   2026
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.